This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and technologies that are being used in 2012, as well as those that may become major market factors by the end of the forecast period. The report describes the industry, its relationship to various healthcare channels, and the trends for the future. The report's market analysis encompasses drug delivery technology and the revenues earned from licensing that technology. Secondly, it encompasses the pharmaceutical arena as well.
In this report, the market is segmented into two main categories:
Drug delivery technology has come into its own in the last 25 years. Initially seen as merely a medium for a drug substance, drug delivery technologies are now viewed as tools for modifying the pharmacologic properties of drugs, improving methods of delivery, and targeting drugs to specific locations. Progress in the fields of microencapulation, polymer technology and nanoparticles now allow scientists to prolong the effect of drugs with short half-lives. Companies are developing a new generation of sophisticated delivery systems. Targeted delivery has already advanced with new polymer-based chemotherapy implants.The geographic scope of the report is worldwide. Numbers provided in this report represent global market sizes and revenues with no regional breakout. In terms of products, the report includes data on needle-free injection delivery and implantable delivery, which includes sustained release delivery and targeted delivery systems.
As part of its extensive coverage, this report provide the following information:
Needle-free jet injection devices can and should play a major role in solving the problems of needle-stick injuries and needle phobia in the United States. However, the needle-free jet injector industry is struggling to overcome significant obstacles in this country and abroad before these devices become widely accepted and used for administering drugs and especially vaccines. Most needle-free jet injectors use metal springs, compressed air, or CO2 gas to power the injection. The device's nozzle is held against the patient's skin and once activated, the device injects a fine stream of the vaccine or drug at a high pressure into the skin. The most common orifice size is 0.127 mm, whereas that of a 25-gauge needle is 1 mm.
As the discovery and development of new drugs create the promise of relief and improved levels of care for a variety of chronic conditions, developers are increasingly aware of the need to pair these promising new therapies, more than half of which cannot be taken orally, with delivery methods that are patient-friendly and that encourage compliance. These combination products, in which the delivery device is an integral part of the approved drug therapy, must take into account the needs of a broad range of end users, including elderly patients and those with compromised dexterity, a rapidly-growing demographic segment of the population in developed countries. For many drug developers, the answer to this challenge will increasingly be needle-free injection. While the concept behind needle-free injection is uncomplicated, it has only been recently, with the convergence of synthetic materials and computerized design software that reliable and cost-effective devices have begun to appear. New designs currently being developed will create new opportunities for needle-free injection.
The technology continues to advance as needle-free company marketers are evolving, searching for a strategy that will achieve commercial success. Companies have invested in new device models that incorporate design enhancements and improved engineering. The new generation of devices are lighter, have a sleek profile, and employ warm colors.
The number of companies providing implantable/injectable drug delivery platforms continues to proliferate. The implantable/injectable drug delivery industry is comprised of companies seeking to develop novel alternatives to existing delivery systems, enhancements to existing systems, commercially enabling delivery systems that provide viable alternatives for therapeutics that are not fully developed and marketed because there are limited practical means of administration. This report provides profiles of the following companies
This market analysis does not include drug-eluding stents or regular syringes. All market data pertain to the worldwide market at the manufacturers’ level and are measured in U.S. dollars. The base year for data was 2012. Historical data are provided for 2010 and 2011, with forecast data provided for 2013 through 2017. Compound annual growth rates are provided for three periods: 2010–2012, 2012–2017, and 2010–2017.
Related Reports:Outsourcing in Drug Discovery, 7th Edition
Apr 26, 2016 - KLI5979268 - $4,200.00
Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Mar 25, 2016 - KLI5948213 - $4,200.00
The World Market for Laboratory Information Systems
Feb 11, 2016 - KLI5881925 - $4,200.00
World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other)
Jan 22, 2016 - KLI5757702 - $8,800.00
The World Market for Microarrays
Jan 13, 2016 - KLI5827689 - $4,200.00
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)
Dec 10, 2015 - KLI5789361 - $4,200.00
Transdermal and Transmucosal Drug Delivery Markets
Nov 25, 2015 - KLI5774708 - $3,995.00
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment
Nov 12, 2015 - KLI5752001 - $4,200.00
The World Market for Liquid Chromatography in Healthcare
Nov 1, 2015 - KLI5733398 - $4,500.00
The World Market for Infectious Disease Diagnostic Tests
Nov 1, 2015 - KLI5721838 - $4,500.00
Questions?Contact a research specialist >
Live Chat Software
Most Popular ResearchRetail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments) The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 6th Edition Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment Out-of-Pocket Healthcare Expenditures in the United States